Sub-group analysis | n | Estimates | 95% CI | p | I2 | P for subgroup |
---|---|---|---|---|---|---|
Adjustmenta |  |  |  |  |  |  < 0.001 |
 Adjustment | 4 | -0.08 | -0.16, -0.01 | 0.03 | 0 |  |
 Non-adjustment | 13 | -0.46 | -0.65, -0.28 |  < 0.0001 | 82.4 |  |
Type of stroke | Â | Â | Â | Â | Â | 0.099 |
 All | 13 | -0.36 | -0.56, -0.16 | 0.0004 | 91.6 |  |
 Ischemic | 3 | -0.48 | -0.68, -0.29 |  < 0.0001 | 0 |  |
 Haemorrhagic | 1 | 0 | -0.40, 0.40 |  |  |  |
Study designed specifically to investigate SES and HRQoL | ||||||
 No | 6 | -0.42 | -0.79, -0.04 | 0.028 | 91.0 | 0.860 |
 Yes | 3 | -0.29 | -0.58, 0.01 | 0.059 | 72.7 |  |
 Predictors | 8 | -0.33 | -0.52, -0.15 | 0.0004 | 78.8 |  |
Population age (mean, years) | ||||||
  > 65 | 11 | -0.35 | -0.58, -0.13 | 0.002 | 89.5 | 0.982 |
  ≤ 65 | 6 | -0.38 | -0.59, -0.17 |  < 0.001 | 68.7 |  |
Follow-up time (mean, month) | ||||||
  < 3 | 5 | -0.38 | -0.58, -0.18 |  < 0.001 | 42.8 | 0.392 |
 3–12 | 4 | -0.14 | -0.40, 0.11 | 0.27 | 69.8 |  |
  > 12 | 2 | -0.48 | -1.14, 0.19 | 0.16 | 92.2 |  |
 Not available | 6 | -0.46 | -0.79, -0.12 | 0.008 | 95.1 |  |
Study year | Â | Â | Â | Â | Â | 0.119 |
 Before 2016 | 9 | -0.23 | -0.38, -0.09 |  < 0.001 | 76.6 |  |
 2016 and later | 8 | -0.49 | -0.76, -0.21 |  < 0.001 | 86.2 |  |
Study setting | Â | Â | Â | Â | Â | 0.024 |
 Hospital/Clinic | 14 | -0.41 | -0.61, -0.22 |  < 0.001 | 81.7 |  |
 Community | 3 | -0.16 | -0.27, -0.05 | 0.003 | 61.3 |  |
SES regionb | Â | Â | Â | Â | Â | 0.929 |
 High – upper middle | 12 | -0.36 | -0.58, -0.14 | 0.0011 | 92.6 |  |
 Low – lower middle | 5 | -0.37 | -0.57, -0.18 | 0.0002 | 41.9 |  |